Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin and B-vitamins on Endothelial Function in CAD/PAD
NCT00693589Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Jan 2005
- Primary completion
- Feb 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 2, randomised, double-blind trial of rosuvastatin, folic acid, cyanocobalamin and pyridoxine in coronary artery disease (CAD), peripheral artery disease (PAD) and endothelial dysfunction, sponsored by Insel Gruppe. Started Jan 2005; status: completed.
02
Drugs
rosuvastatinfolic acidcyanocobalaminpyridoxine
03
Conditions
coronary artery disease (CAD)peripheral artery disease (PAD)endothelial dysfunction
Beyond the preview
Go deeper on NCT00693589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00693589.